Variables | Total (n=1543) | Survival group (n=1249) | Death group (n=294) | P |
---|---|---|---|---|
Age, year, Mean ± SD | 61.61 ± 16.19 | 60.01 ± 16.40 | 68.39 ± 13.27 | <0.001 |
Gender, n (%) | 0.690 | |||
Female | 567 (36.75) | 456 (36.51) | 111 (37.76) | |
Male | 976 (63.25) | 793 (63.49) | 183 (62.24) | |
Ethnicity, n (%) | 0.024 | |||
White | 892 (57.81) | 733 (58.69) | 159 (54.08) | |
Black | 168 (10.89) | 143 (11.45) | 25 (8.50) | |
Other | 177 (11.47) | 143 (11.45) | 34 (11.56) | |
Unknown | 306 (19.83) | 230 (18.41) | 76 (25.85) | |
Insurance, n (%) | 0.019 | |||
Medicaid | 143 (9.27) | 120 (9.61) | 23 (7.82) | |
Medicare | 664 (43.03) | 516 (41.31) | 148 (50.34) | |
Other | 736 (47.70) | 613 (49.08) | 123 (41.84) | |
Marital status, n (%) | <0.001 | |||
Divorced | 123 (7.97) | 88 (7.05) | 35 (11.90) | |
Married | 758 (49.13) | 604 (48.36) | 154 (52.38) | |
Single | 505 (32.73) | 437 (34.99) | 68 (23.13) | |
Widowed | 157 (10.17) | 120 (9.61) | 37 (12.59) | |
Weight, kg, Mean ± SD | 85.16 ± 26.67 | 85.69 ± 27.11 | 82.92 ± 24.62 | 0.089 |
Heart rate, bpm, Mean ± SD | 90.71 ± 21.48 | 90.82 ± 21.40 | 90.23 ± 21.86 | 0.677 |
SBP, mmHg, Mean ± SD | 124.70 ± 26.60 | 125.02 ± 26.41 | 123.35 ± 27.41 | 0.332 |
DBP, mmHg, Mean ± SD | 69.08 ± 18.49 | 69.61 ± 18.49 | 66.81 ± 18.32 | 0.019 |
Respiratory rate, bpm, Mean ± SD | 19.88 ± 6.12 | 19.78 ± 6.14 | 20.28 ± 6.02 | 0.212 |
Temperature, ℃, Mean ± SD | 36.74 ± 1.01 | 36.77 ± 0.99 | 36.58 ± 1.07 | 0.004 |
WBC, K/uL, M (Q1, Q3) | 11.90 (8.70, 16.30) | 11.90 (8.70, 16.10) | 12.20 (9.10, 17.50) | 0.155 |
PLT, K/uL, M (Q1, Q3) | 193.00 (135.00, 254.00) | 194.00 (135.00, 254.00) | 187.50 (135.00, 257.00) | 0.989 |
Hemoglobin, g/dL, Mean ± SD | 10.90 ± 2.43 | 10.98 ± 2.43 | 10.57 ± 2.42 | 0.010 |
RDW, %, Mean ± SD | 15.16 ± 2.33 | 15.06 ± 2.29 | 15.59 ± 2.46 | <0.001 |
Creatinine, mg/dL, M (Q1, Q3) | 1.00 (0.80, 1.60) | 1.00 (0.70, 1.60) | 1.30 (0.80, 1.90) | <0.001 |
INR, ratio, M (Q1, Q3) | 1.20 (1.10, 1.50) | 1.20 (1.10, 1.50) | 1.30 (1.10, 1.70) | 0.008 |
BUN, mg/dL, M (Q1, Q3) | 21.00 (14.00, 34.00) | 20.00 (13.00, 31.00) | 26.00 (17.00, 45.00) | <0.001 |
Glucose, mg/dL, M (Q1, Q3) | 139.00 (111.00, 181.00) | 139.00 (111.00, 181.00) | 138.50 (112.00, 187.00) | 0.535 |
SPO2, %, Mean ± SD | 96.92 ± 4.56 | 96.97 ± 4.57 | 96.68 ± 4.49 | 0.314 |
Anion gap, mEq/L, Mean ± SD | 15.43 ± 4.82 | 15.25 ± 4.76 | 16.20 ± 5.01 | 0.002 |
Congestive heart failure (Yes), n (%) | 502 (32.53) | 374 (29.94) | 128 (43.54) | <0.001 |
Sepsis (Yes), n (%) | 1248 (80.88) | 1003 (80.30) | 245 (83.33) | 0.235 |
Respiratory failure (Yes), n (%) | 851 (55.15) | 664 (53.16) | 187 (63.61) | 0.001 |
GCS, score, M (Q1, Q3) | 8.00 (4.00, 12.00) | 8.00 (5.00, 12.00) | 7.00 (3.00, 11.00) | <0.001 |
CCI, score, M (Q1, Q3) | 3.00 (1.00, 4.00) | 2.00 (1.00, 4.00) | 4.00 (2.00, 5.00) | <0.001 |
SOFA, score, M (Q1, Q3) | 8.00 (5.00, 11.00) | 8.00 (5.00, 11.00) | 9.00 (6.00, 12.00) | <0.001 |
SAPSII, score, M (Q1, Q3) | 40.00 (31.00, 50.00) | 38.00 (30.00, 48.00) | 46.00 (37.00, 56.00) | <0.001 |
Vasopressors (Yes), n (%) | 1044 (67.66) | 818 (65.49) | 226 (76.87) | <0.001 |
RRT (Yes), n (%) | 293 (18.99) | 210 (16.81) | 83 (28.23) | <0.001 |
Thiamine (Yes), n (%) | 254 (16.46) | 214 (17.13) | 40 (13.61) | 0.142 |
Antibiotics use | ||||
Vancomycin (Yes), n (%) | 1382 (89.57) | 1114 (89.19) | 268 (91.16) | 0.321 |
Cephalosporins (Yes), n (%) | 1228 (79.59) | 994 (79.58) | 234 (79.59) | 0.998 |
Penicillin (Yes), n (%) | 721 (46.73) | 598 (47.88) | 123 (41.84) | 0.062 |
Aminoglycoside (Yes), n (%) | 207 (13.42) | 174 (13.93) | 33 (11.22) | 0.221 |
Others, n (%) | 1055 (68.37) | 849 (67.97) | 206 (70.07) | 0.487 |
Pathogen | ||||
Gram-negative bacteria | ||||
Escherichia coli (Yes), n (%) | 185 (11.99) | 154 (12.33) | 31 (10.54) | 0.396 |
Klebsiella pneumoniae (Yes), n (%) | 172 (11.15) | 138 (11.05) | 34 (11.56) | 0.800 |
Pseudomonas aeruginosa (Yes), n (%) | 224 (14.52) | 188 (15.05) | 36 (12.24) | 0.219 |
Serratia marcescens (Yes), n (%) | 61 (3.95) | 49 (3.92) | 12 (4.08) | 0.900 |
Proteus (Yes), n (%) | 50 (3.24) | 42 (3.36) | 8 (2.72) | 0.576 |
Acinetobacter (Yes), n (%) | 53 (3.43) | 38 (3.04) | 15 (5.10) | 0.081 |
Haemophilus influenzae (Yes), n (%) | 115 (7.45) | 97 (7.77) | 18 (6.12) | 0.334 |
Gram-positive bacteria | ||||
Methicillin resistant staph aureus (Yes), n (%) | 102 (6.61) | 78 (6.24) | 24 (8.16) | 0.234 |
Staph aureus coag + (Yes), n (%) | 477 (30.91) | 389 (31.14) | 88 (29.93) | 0.686 |
Streptococcus pneumoniae (Yes), n (%) | 37 (2.40) | 30 (2.40) | 7 (2.38) | 0.983 |
Fungus (Yes), n (%) | 133 (8.62) | 101 (8.09) | 32 (10.88) | 0.124 |
Duration of mechanical ventilation, hour, M (Q1, Q3) | 151.53 (76.00, 268.27) | 153.00 (78.00, 278.50) | 146.38 (67.18, 233.50) | 0.014 |
Follow-up, day, M (Q1, Q3) | 30.00 (30.00, 30.00) | 30.00 (30.00, 30.00) | 13.27 (9.14, 18.55) | <0.001 |